Knupp C A, Swanson S P, Buck W B
Department of Veterinary Biosciences, College of Veterinary Medicine, University of Illinois, Urbana 61801.
Food Chem Toxicol. 1987 Nov;25(11):859-65. doi: 10.1016/0278-6915(87)90265-1.
Hepatic microsomes were prepared from phenobarbital (PB)-treated and control rats, mice, rabbits and chickens and were incubated with T-2 toxin (100 micrograms/mg microsomal protein). Additional microsomes from PB-induced animals were incubated with T-2 toxin and the esterase inhibitor paraoxon (PA) at 2.5 nmol/mg microsomal protein. The major metabolite in microsomal preparations from both control and PB-induced rats, rabbits and mice was HT-2. In microsomes isolated from PB-treated chickens, 3'-hydroxy T-2 was the major metabolite, but 30 and 79% of the added T-2 toxin remained unmetabolized at 60 min in incubations from PB-induced and control birds, respectively. The percentage of hydroxylated metabolites formed in the microsomal preparations of the four species studied was significantly increased following PB treatment compared with the non-treated controls. The addition of PA to the incubation system effectively inhibited the hydrolysis of the ester groups in T-2 toxin, resulting in 1.4- and 1.25-fold increases in the percentage of 3'-hydroxy T-2 in the mouse and rat microsomal samples, respectively. In the rabbit microsomal preparations, 3'-hydroxy T-2, which was not detected in the absence of PA, represented 11% of the added substrate in the PB/PA incubation samples. Addition of PA did not cause a significant change in the amount of 3'-hydroxy T-2 formed in chicken microsomal samples, since competition between hydrolysis and hydroxylation pathways for the T-2 toxin substrate was not an important factor in this species. Two new metabolites, designated RLM-2 and RLM-3 were detected in chicken, rat and mouse microsomal preparations. On the basis of gas chromatography/mass spectrometry data, the compounds were tentatively identified as isomers of 3'-hydroxy T-2.
从经苯巴比妥(PB)处理的以及对照的大鼠、小鼠、兔子和鸡中制备肝微粒体,并将其与T-2毒素(100微克/毫克微粒体蛋白)一起孵育。来自PB诱导动物的额外微粒体与T-2毒素和酯酶抑制剂对氧磷(PA)以2.5纳摩尔/毫克微粒体蛋白的浓度一起孵育。对照和PB诱导的大鼠、兔子和小鼠的微粒体制剂中的主要代谢产物是HT-2。在从经PB处理的鸡中分离出的微粒体中,3'-羟基T-2是主要代谢产物,但在来自PB诱导和对照鸡的孵育体系中,分别有30%和79%添加的T-2毒素在60分钟时仍未代谢。与未处理的对照相比,PB处理后,所研究的四种物种的微粒体制剂中形成的羟基化代谢产物的百分比显著增加。向孵育体系中添加PA有效地抑制了T-2毒素中酯基的水解,导致小鼠和大鼠微粒体样品中3'-羟基T-2的百分比分别增加了1.4倍和1.25倍。在兔子微粒体制剂中,在没有PA的情况下未检测到的3'-羟基T-2在PB/PA孵育样品中占添加底物的11%。添加PA并未使鸡微粒体样品中形成的3'-羟基T-2的量发生显著变化,因为T-2毒素底物的水解和羟基化途径之间的竞争在该物种中不是一个重要因素。在鸡、大鼠和小鼠的微粒体制剂中检测到两种新的代谢产物,命名为RLM-2和RLM-3。根据气相色谱/质谱数据,这些化合物被初步鉴定为3'-羟基T-2的异构体。